Viking Therapeutics
VKTX
#3882
Rank
$3.33 B
Marketcap
$26.17
Share price
-2.64%
Change (1 day)
-30.69%
Change (1 year)

EPS for Viking Therapeutics (VKTX)

EPS in 2026 (TTM): -$5.40

According to Viking Therapeutics 's latest financial reports the company's current EPS (TTM) is -$5.40. In 2025 the company made an earnings per share (EPS) of -$3.18 a decrease over its 2024 EPS that were of -$1.00.

EPS history for Viking Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$5.4069.81%
2025-$3.18218%
2024-$1.00
2022-$0.9126.39%
2021-$0.7233.33%
2020-$0.54
2018-$0.39-51.25%
2017-$0.80-20%
2016-$1.00-64.08%
2015-$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
-$5.19-3.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-$0.20-96.30%๐Ÿ‡บ๐Ÿ‡ธ USA